Radiotheranostics Market (2026 - 2033) Size, Share & Trends Analysis Report By Radioisotope (Iodine-131, Iodine-123, Gallium-68), By Approach (Targeted Therapeutic, Targeted Diagnostic), By Application (Oncology, Non-Oncology), By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1 Market Segmentation & Scope
                    1.2 Segment Definitions
                        1.2.1 Radioisotope
                        1.2.2 Approach
                        1.2.3 Application
                    1.3 Estimates and Forecast Timeline
                    1.4 Research Methodology
                    1.5 Information Procurement
                        1.5.1 Purchased Database
                        1.5.2 GVR’s Internal Database
                        1.5.3 Secondary Sources
                        1.5.4 Primary Research
                    1.6 Information Analysis
                        1.6.1 Data Analysis Models
                    1.7 Market Formulation & Data Visualization
                    1.8 Model Details
                        1.8.1 Commodity Flow Analysis
                    1.9 List of Secondary Sources
                    1.10 Objectives
Chapter 2. Executive Summary
                    2.1 Market Snapshot
                    2.2 Segment Snapshot
                    2.3 Competitive Landscape Snapshot
Chapter 3 Radiotheranostics Market Variables, Trends, & Scope
                    3.1 Market Lineage Outlook
                    3.2 Market Dynamics
                        3.2.1 Market Driver Analysis
                        3.2.2 Market Restraint Analysis
                    3.3 Business Environment Analysis
                        3.3.1 Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1 Supplier Power
                            3.3.1.2 Buyer Power
                            3.3.1.3 Substitution Threat
                            3.3.1.4 Threat of New Entrants
                            3.3.1.5 Competitive Rivalry
                        3.3.2 PESTLE Analysis
                        3.3.3 Pipeline Analysis
                        3.3.4 Patent Expiry Analysis
                        3.3.5 Pricing Analysis
Chapter 4. Radiotheranostics Market: Radioisotope Business Analysis
                    4.1. Radioisotope Market Share, 2025 & 2033
                    4.2. Radioisotope Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Radioisotope, 2021 to 2033 (USD Million)
                    4.4. Iodine-131
                        4.4.1 Iodine-131 Market, 2021 - 2033 (USD Million)
                    4.5. Iodine-123
                        4.5.1 Iodine-123 Market, 2021 - 2033 (USD Million)
                    4.6. Gallium-68
                        4.6.1 Gallium-68 Market, 2021 - 2033 (USD Million)
                    4.7. Lutetium-177
                        4.7.1 Lutetium-177 Market, 2021 - 2033 (USD Million)
                    4.8. 18F with Y-90
                        4.8.1 18F with Y-90 Market, 2021 - 2033 (USD Million)
                    4.9. Others
                        4.9.1 Others Market, 2021 - 2033 (USD Million)
Chapter 5. Radiotheranostics Market: Approach Business Analysis
                    5.1. Approach Market Share, 2025 & 2033
                    5.2. Approach Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Approach, 2021 to 2033 (USD Million)
                    5.4. Targeted Therapeutic
                        5.4.1 Targeted Therapeutic Market, 2021 - 2033 (USD Million)
                    5.5. Targeted Diagnostic
                        5.5.1 Targeted Diagnostic Market, 2021 - 2033 (USD Million)
Chapter 6. Radiotheranostics Market: Application Business Analysis
                    6.1. Application Market Share, 2025 & 2033
                    6.2. Application Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    6.4. Oncology
                        6.4.1 Oncology Market, 2021 - 2033 (USD Million)
                            6.4.1.1 Thyroid Cancer Market, 2021 - 2033 (USD Million)
                            6.4.1.2 Neuroendocrine Tumor Market, 2021 - 2033 (USD Million)
                            6.4.1.3 Hepatocellular Carcinoma Market, 2021 - 2033 (USD Million)
                            6.4.1.4 Prostate Cancer Market, 2021 - 2033 (USD Million)
                            6.4.1.5 Others Market, 2021 - 2033 (USD Million)
                    6.5. Non-Oncology
                        6.5.1 Non-Oncology Market, 2021 - 2033 (USD Million)
                            6.5.1.1 Neurological Disorders Market, 2021 - 2033 (USD Million)
                            6.5.1.2 Arthritis Market, 2021 - 2033 (USD Million)
                            6.5.1.3 Others Market, 2021 - 2033 (USD Million)
Chapter 7. Radiotheranostics Market: Regional Estimates & Trend Analysis
                    7.1 Regional Market Share Analysis, 2025 & 2033
                    7.2 Regional Market Dashboard
                    7.3 Market Size & Forecasts Trend Analysis, 2021 to 2033:
                    7.4 North America
                        7.4.1 North America Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
                        7.4.2 U.S.
                            7.4.2.1 Key Country Dynamics
                            7.4.2.2 Regulatory Framework
                            7.4.2.3 Reimbursement Scenario
                            7.4.2.4 U.S. Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.4.3 Canada
                            7.4.3.1 Key Country Dynamics
                            7.4.3.2 Regulatory Framework
                            7.4.3.3 Reimbursement Scenario
                            7.4.3.4 Canada Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.4.4 Mexico
                            7.4.4.1 Key Country Dynamics
                            7.4.4.2 Regulatory Framework
                            7.4.4.3 Reimbursement Scenario
                            7.4.4.4 Mexico Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                    7.5 Europe
                        7.5.1 Europe Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
                        7.5.2 UK
                            7.5.2.1 Key Country Dynamics
                            7.5.2.2 Regulatory Framework
                            7.5.2.3 Reimbursement Scenario
                            7.5.2.4 UK Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.5.3 Germany
                            7.5.3.1 Key Country Dynamics
                            7.5.3.2 Regulatory Framework
                            7.5.3.3 Reimbursement Scenario
                            7.5.3.4 Germany Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.5.4 France
                            7.5.4.1 Key Country Dynamics
                            7.5.4.2 Regulatory Framework
                            7.5.4.3 Reimbursement Scenario
                            7.5.4.4 France Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.5.5 Italy
                            7.5.5.1 Key Country Dynamics
                            7.5.5.2 Regulatory Framework
                            7.5.5.3 Reimbursement Scenario
                            7.5.5.4 Italy Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.5.6 Spain
                            7.5.6.1 Key Country Dynamics
                            7.5.6.2 Regulatory Framework
                            7.5.6.3 Reimbursement Scenario
                            7.5.6.4 Spain Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.5.7 Denmark
                            7.5.7.1 Key Country Dynamics
                            7.5.7.2 Regulatory Framework
                            7.5.7.3 Reimbursement Scenario
                            7.5.7.4 Denmark Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.5.8 Norway
                            7.5.8.1 Key Country Dynamics
                            7.5.8.2 Regulatory Framework
                            7.5.8.3 Reimbursement Scenario
                            7.5.8.4 Norway Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.5.9 Sweden
                            7.5.7.1 Key Country Dynamics
                            7.5.7.2 Regulatory Framework
                            7.5.7.3 Reimbursement Scenario
                            7.5.7.4 Sweden Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                    7.6 Asia Pacific
                        7.6.1 Asia Pacific Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
                        7.6.2 Japan
                            7.6.2.1 Key Country Dynamics
                            7.6.2.2 Regulatory Framework
                            7.6.2.3 Reimbursement Scenario
                            7.6.2.4 Japan Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.6.3 China
                            7.6.3.1 Key Country Dynamics
                            7.6.3.2 Regulatory Framework
                            7.6.3.3 Reimbursement Scenario
                            7.6.3.4 China Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.6.4 India
                            7.6.4.1 Key Country Dynamics
                            7.6.4.2 Regulatory Framework
                            7.6.4.3 Reimbursement Scenario
                            7.6.4.4 India Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.6.5 South Korea
                            7.6.5.1 Key Country Dynamics
                            7.6.5.2 Regulatory Framework
                            7.6.5.3 Reimbursement Scenario
                            7.6.5.4 South Korea Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.6.6 Australia
                            7.6.6.1 Key Country Dynamics
                            7.6.6.2 Regulatory Framework
                            7.6.6.3 Reimbursement Scenario
                            7.6.6.4 Australia Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.6.7 Thailand
                            7.6.7.1 Key Country Dynamics
                            7.6.7.2 Regulatory Framework
                            7.6.7.3 Reimbursement Scenario
                            7.6.7.4 Thailand Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                    7.7 Latin America
                        7.7.1 Latin America Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
                        7.7.2 Brazil
                            7.7.2.1 Key Country Dynamics
                            7.7.2.2 Regulatory Framework
                            7.7.2.3 Reimbursement Scenario
                            7.7.2.4 Brazil Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.7.3 Argentina
                            7.7.3.1 Key Country Dynamics
                            7.7.3.2 Regulatory Framework
                            7.7.3.3 Reimbursement Scenario
                            7.7.3.4 Argentina Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                    7.8 Middle East & Africa
                        7.8.1 Middle East & Africa Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
                        7.8.2 South Africa
                            7.8.2.1 Key Country Dynamics
                            7.8.2.2 Regulatory Framework
                            7.8.2.3 Reimbursement Scenario
                            7.8.2.4 South Africa Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.8.3 Saudi Arabia
                            7.8.3.1 Key Country Dynamics
                            7.8.3.2 Regulatory Framework
                            7.8.3.3 Reimbursement Scenario
                            7.8.3.4 Saudi Arabia Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.8.4 UAE
                            7.8.4.1 Key Country Dynamics
                            7.8.4.2 Regulatory Framework
                            7.8.4.3 Reimbursement Scenario
                            7.8.4.4 UAE Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
                        7.8.5 Kuwait
                            7.8.5.1 Key Country Dynamics
                            7.8.5.2 Regulatory Framework
                            7.8.5.3 Reimbursement Scenario
                            7.8.5.4 Kuwait Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Participant Overview
                    8.2. Company Market Position Analysis
                    8.3. Company Categorization
                    8.4. Strategy Mapping
                    8.5. Company Profiles/Listing
                        8.5.1 Bayer
                            8.5.1.1 Overview
                            8.5.1.2 Financial Performance
                            8.5.1.3 Product Benchmarking
                            8.5.1.4 Strategic Initiatives
                        8.5.2 Lantheus Holdings
                            8.5.2.1 Overview
                            8.5.2.2 Financial Performance
                            8.5.2.3 Product Benchmarking
                            8.5.2.4 Strategic Initiatives
                        8.5.3 POINT Biopharma
                            8.5.3.1 Overview
                            8.5.3.2 Financial Performance
                            8.5.3.3 Product Benchmarking
                            8.5.3.4 Strategic Initiatives
                        8.5.4 Telix Pharmaceuticals
                            8.5.4.1 Overview
                            8.5.4.2 Financial Performance
                            8.5.4.3 Product Benchmarking
                            8.5.4.4 Strategic Initiatives
                        8.5.5 Actinium Pharmaceuticals
                            8.5.5.1 Overview
                            8.5.5.2 Financial Performance
                            8.5.5.3 Product Benchmarking
                            8.5.5.4 Strategic Initiatives
                        8.5.6 RadioMedix
                            8.5.6.1 Overview
                            8.5.6.2 Financial Performance
                            8.5.6.3 Product Benchmarking
                            8.5.6.4 Strategic Initiatives
                        8.5.7 IsoRay
                            8.5.7.1 Overview
                            8.5.7.2 Financial Performance
                            8.5.7.3 Product Benchmarking
                            8.5.7.4 Strategic Initiatives
                        8.5.8 SHINE Technologies
                            8.5.8.1 Overview
                            8.5.8.2 Financial Performance
                            8.5.8.3 Product Benchmarking
                            8.5.8.4 Strategic Initiatives
                        8.5.9 NorthStar Medical Radioisotopes
                            8.5.9.1 Overview
                            8.5.9.2 Financial Performance
                            8.5.9.3 Product Benchmarking
                            8.5.9.4 Strategic Initiatives
                        8.5.10 Fusion Pharmaceuticals
                            8.5.10.1 Overview
                            8.5.10.2 Financial Performance
                            8.5.10.3 Product Benchmarking
                            8.5.10.4 Strategic Initiatives
                        8.5.11 Novartis
                            8.5.11.1 Overview
                            8.5.11.2 Financial Performance
                            8.5.11.3 Product Benchmarking
                            8.5.11.4 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Radiotheranostics Market Market, by Region, 2021 - 2033 (USD Million)
Table 4 Global Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 5 Global Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 6 Global Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 7 North America Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 8 North America Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 9 North America Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 10 North America Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 11 U.S. Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 12 U.S. Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 13 U.S. Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 14 Canada Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 15 Canada Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 16 Canada Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 17 Mexico Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 18 Mexico Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 19 Mexico Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 20 Europe Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 21 Europe Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 22 Europe Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 23 Europe Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 24 UK Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 25 UK Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 26 UK Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 27 Germany Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 28 Germany Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 29 Germany Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 30 France Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 31 France Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 32 France Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 33 Italy Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 34 Italy Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 35 Italy Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 36 Spain Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 37 Spain Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 38 Spain Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 39 Denmark Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 40 Denmark Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 41 Denmark Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 42 Norway Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 43 Norway Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 44 Norway Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 45 Sweden Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 46 Sweden Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 47 Sweden Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 48 Asia Pacific Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 49 Asia Pacific Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 50 Asia Pacific Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 51 Asia Pacific Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 52 Japan Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 53 Japan Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 54 Japan Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 55 China Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 56 China Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 57 China Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 58 India Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 59 India Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 60 India Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 61 South Korea Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 62 South Korea Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 63 South Korea Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 64 Australia Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 65 Australia Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 66 Australia Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 67 Thailand Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 68 Thailand Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 69 Thailand Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 70 Latin America Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 71 Latin America Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 72 Latin America Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 73 Latin America Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 74 Brazil Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 75 Brazil Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 76 Brazil Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 77 Argentina Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 78 Argentina Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 79 Argentina Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 80 Middle East & Africa Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 81 Middle East & Africa Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 82 Middle East & Africa Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 83 Middle East & Africa Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 84 South Africa Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 85 South Africa Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 86 South Africa Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 89 Saudi Arabia Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 90 UAE Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 91 UAE Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 92 UAE Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 93 Kuwait Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 94 Kuwait Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 95 Kuwait Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Radiotheranostics Market: market outlook
Fig. 14 Radiotheranostics Market: competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Radiotheranostics Market driver impact
Fig. 20 Radiotheranostics Market restraint impact
Fig. 21 Radiotheranostics Market strategic initiatives analysis
Fig. 22 Radiotheranostics Market: Radioisotope movement analysis
Fig. 23 Radiotheranostics Market: Radioisotope outlook and key takeaways
Fig. 24 Iodine-131 market estimates and forecast, 2021 - 2033
Fig. 25 Iodine-123 market estimates and forecast, 2021 - 2033
Fig. 26 Gallium-68 market estimates and forecast, 2021 - 2033
Fig. 27 Lutetium-177 market estimates and forecast, 2021 - 2033
Fig. 28 18F with Y-90 market estimates and forecast, 2021 - 2033
Fig. 29 Others market estimates and forecasts, 2021 - 2033
Fig. 30 Radiotheranostics Market: Approach movement analysis
Fig. 31 Radiotheranostics Market: Approach outlook and key takeaways
Fig. 32 Targeted Therapeutic market estimates and forecast, 2021 - 2033
Fig. 33 Targeted Diagnostic market estimates and forecast, 2021 - 2033
Fig. 34 Radiotheranostics Market: Application movement analysis
Fig. 35 Radiotheranostics Market: Application outlook and key takeaways
Fig. 36 Oncology market estimates and forecast, 2021 - 2033
Fig. 37 Thyroid Cancer market estimates and forecast, 2021 - 2033
Fig. 38 Neuroendocrine Tumor market estimates and forecast, 2021 - 2033
Fig. 39 Hepatocellular Carcinoma market estimates and forecast, 2021 - 2033
Fig. 40 Prostate Cancer market estimates and forecast, 2021 - 2033
Fig. 41 Others market estimates and forecasts, 2021 - 2033
Fig. 42 Non-Oncology market estimates and forecast, 2021 - 2033
Fig. 43 Neurological Disorders market estimates and forecast, 2021 - 2033
Fig. 44 Arthritis market estimates and forecast, 2021 - 2033
Fig. 45 Others market estimates and forecasts, 2021 - 2033
Fig. 46 Radiotheranostics Market: Regional movement analysis
Fig. 47 Radiotheranostics Market: Regional outlook and key takeaways
Fig. 48 Radiotheranostics Market share and leading players
Fig. 49 North America Radiotheranostics Market share and leading players
Fig. 50 Europe Radiotheranostics Market share and leading players
Fig. 51 Asia Pacific Radiotheranostics Market share and leading players
Fig. 52 Latin America Radiotheranostics Market share and leading players
Fig. 53 Middle East & Africa Radiotheranostics Market share and leading players
Fig. 54 North America Radiotheranostics Market SWOT Analysis
Fig. 55 Europe Radiotheranostics Market SWOT Analysis
Fig. 56 Asia Pacific Radiotheranostics Market SWOT Analysis
Fig. 57 Latin America Radiotheranostics Market SWOT Analysis
Fig. 58 Middle East & Africa Radiotheranostics Market SWOT Analysis
Fig. 59 North America Radiotheranostics Market Analysis, by country
Fig. 60 North America
Fig. 61 North America Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 62 U.S.
Fig. 63 U.S. Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 64 Canada
Fig. 65 Canada Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 66 Mexico
Fig. 67 Mexico Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 68 Europe
Fig. 69 Europe Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 70 UK
Fig. 71 UK Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 72 Germany
Fig. 73 Germany Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 74 France
Fig. 75 France Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 76 Italy
Fig. 77 Italy Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 78 Spain
Fig. 79 Spain Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 80 Denmark
Fig. 81 Denmark Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 82 Sweden
Fig. 83 Sweden Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 84 Norway
Fig. 85 Norway Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 86 Asia Pacific
Fig. 87 Asia Pacific Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 88 China
Fig. 89 China Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 90 Japan
Fig. 91 Japan Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 92 India
Fig. 93 India Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 94 Thailand
Fig. 95 Thailand Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 96 South Korea
Fig. 97 South Korea Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 98 Australia
Fig. 99 Australia Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 100 Latin America
Fig. 101 Latin America Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 102 Brazil
Fig. 103 Brazil Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 104 Argentina
Fig. 105 Argentina Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 106 Middle East & Africa
Fig. 107 Middle East & Africa Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 108 South Africa
Fig. 109 South Africa Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 110 Saudi Arabia
Fig. 111 Saudi Arabia Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 112 UAE
Fig. 113 UAE Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 114 Kuwait
Fig. 115 Kuwait Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 116 Market share of key market players - Radiotheranostics Market